NASDAQ:LIVN LivaNova (LIVN) Stock Price, News & Analysis $36.28 -0.50 (-1.36%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$36.28 -0.01 (-0.01%) As of 05/5/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About LivaNova Stock (NASDAQ:LIVN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LivaNova alerts:Sign Up Key Stats Today's Range$36.24▼$36.9950-Day Range$33.85▼$41.7252-Week Range$32.48▼$64.48Volume1.34 million shsAverage Volume613,793 shsMarket Capitalization$1.98 billionP/E Ratio86.38Dividend YieldN/APrice Target$61.17Consensus RatingModerate Buy Company OverviewLivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.Read More… LivaNova Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreLIVN MarketRank™: LivaNova scored higher than 75% of companies evaluated by MarketBeat, and ranked 217th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingLivaNova has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageLivaNova has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LivaNova's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.18% Earnings GrowthEarnings for LivaNova are expected to grow by 10.18% in the coming year, from $2.85 to $3.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LivaNova is 86.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.95.Price to Earnings Ratio vs. SectorThe P/E ratio of LivaNova is 86.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.56.Price to Book Value per Share RatioLivaNova has a P/B Ratio of 1.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LivaNova's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.03% of the float of LivaNova has been sold short.Short Interest Ratio / Days to CoverLivaNova has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LivaNova has recently increased by 0.61%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLivaNova does not currently pay a dividend.Dividend GrowthLivaNova does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.03% of the float of LivaNova has been sold short.Short Interest Ratio / Days to CoverLivaNova has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LivaNova has recently increased by 0.61%, indicating that investor sentiment is decreasing. News and Social Media3.5 / 5News Sentiment1.35 News SentimentLivaNova has a news sentiment score of 1.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for LivaNova this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for LIVN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows2 people have added LivaNova to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, LivaNova insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.27% of the stock of LivaNova is held by insiders.Percentage Held by Institutions97.64% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LivaNova's insider trading history. Receive LIVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter. Email Address LIVN Stock News HeadlinesLivaNova PLC (NASDAQ:LIVN) Receives $61.17 Average Price Target from BrokeragesMay 5 at 1:35 AM | americanbankingnews.comThe UK and Europe’s Performance in Q1 2025April 26, 2025 | uk.finance.yahoo.comWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."May 6, 2025 | Brownstone Research (Ad)Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now?April 26, 2025 | msn.comLivaNova price target lowered to $50 from $60 at MizuhoApril 17, 2025 | markets.businessinsider.comWhat Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing?April 15, 2025 | uk.finance.yahoo.comLivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to BillionairesApril 14, 2025 | msn.comLivaNova PLC: Excellent Revenue Earner, Some Short-Term Litigation ConcernsApril 10, 2025 | seekingalpha.comSee More Headlines LIVN Stock Analysis - Frequently Asked Questions How have LIVN shares performed this year? LivaNova's stock was trading at $46.31 at the beginning of the year. Since then, LIVN shares have decreased by 21.7% and is now trading at $36.28. View the best growth stocks for 2025 here. How were LivaNova's earnings last quarter? LivaNova PLC (NASDAQ:LIVN) released its earnings results on Wednesday, May, 1st. The company reported $0.73 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.28. LivaNova's revenue for the quarter was up 12.0% on a year-over-year basis. Read the conference call transcript. Who are LivaNova's major shareholders? Top institutional shareholders of LivaNova include Victory Capital Management Inc. (1.68%), Emerald Advisers LLC (1.37%), Emerald Mutual Fund Advisers Trust (0.87%) and Allspring Global Investments Holdings LLC (0.53%). Insiders that own company stock include Damien Mcdonald, Daniel Jeffrey Moore and Francesco Bianchi. View institutional ownership trends. How do I buy shares of LivaNova? Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LivaNova own? Based on aggregate information from My MarketBeat watchlists, some other companies that LivaNova investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings5/01/2024Today5/05/2025Next Earnings (Estimated)5/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:LIVN CIK1639691 Webwww.livanova.com Phone442033250660Fax281-218-9332Employees2,900Year FoundedN/APrice Target and Rating Average Stock Price Target$61.17 High Stock Price Target$72.00 Low Stock Price Target$55.00 Potential Upside/Downside+68.6%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$1.14 Trailing P/E Ratio86.38 Forward P/E Ratio12.73 P/E GrowthN/ANet Income$17.55 million Net Margins1.91% Pretax Margin-5.03% Return on Equity13.81% Return on Assets7.07% Debt Debt-to-Equity Ratio0.46 Current Ratio3.37 Quick Ratio2.87 Sales & Book Value Annual Sales$1.25 billion Price / Sales1.58 Cash Flow$3.25 per share Price / Cash Flow11.15 Book Value$23.72 per share Price / Book1.53Miscellaneous Outstanding Shares54,524,000Free Float54,154,000Market Cap$1.98 billion OptionableOptionable Beta0.84 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NASDAQ:LIVN) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.